Table 6.
Author | Participants | Protocol | Results |
---|---|---|---|
De Pauw et al. 2017 [79] | Healthy males (n = 10) |
• Nasal spray 15 mg/mL caffeine • Nasal spray 80 mg/mL glucose • Placebo nasal spray |
*↑ activity of cingulate, insular, and sensory-motor cortices ⬌ stroop task performance |
De Pauw et al. 2017 [80] | Moderately trained males (n = 11) |
• Nasal spray 15 mg/mL caffeine • Nasal spray 80 mg/mL glucose • Placebo nasal spray |
⬌ plasma caffeine levels ⬌ wingate performance ⬌ 30 min cycling TT performance ⬌ stroop task performance |
Laizure et al. 2017 [81] | Healthy adults (n = 17) |
• Inspired powder 100 mg/mL caffeine (AeroShot) • Oral solution 100 mg/248 mL caffeine |
⬌ peak plasma caffeine levels ⬌ bioavailability |
mg/mL = milligram per milliliter, TT = time trial, * = significant difference, ⬌ = no improvement/change, ↑ = increased, ↓ = decreased, min = minute